Outcomes and native renal recovery following simultaneous liver-kidney transplantation

American Journal of Transplantation

Volumn 12, Issue 11, 2012, Pages 2949-2957

  Levitsky, J ^a   Baker, T ^a   Ahya, S N ^a   Levin, M L ^a   Friedewald, J ^a   Gallon, L ^a   Ho, B ^a   Skaro, A ^a   Krupp, J ^a   Wang, E ^a,b   Spies, S M ^b   Salomon, D R ^c   Abecassis, M M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Glomerular filtration rate; kidney injury; liver transplantation; renal recovery; renal scan

Indexed keywords

CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTETATE TECHNETIUM TC 99M; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY SCINTISCANNING; KIDNEY TRANSPLANTATION; LIVER GRAFT REJECTION; LIVER KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UNITED NETWORK FOR ORGAN SHARING SCORE;

ADULT; ANALYSIS OF VARIANCE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE CARE; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84868192570     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04182.x     Document Type: Article

References (49)

1. Nair S, Verma S, Thuluvath PJ,. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179-1185.
2. Campbell MS, Kotlyar DS, Brensinger CM, et al,. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transplant 2005; 11: 1048-1055.
3. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD,. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant 2008; 8: 2243-2251.
4. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS,. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361-365.
5. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N,. Continued influence of preoperative renal function on outcome of orthotopic liver transplant in the US: Where will MELD lead us? Am J Transplant 2006; 6: 2651-2659.
6. Bahirwani R, Campbell MS, Siropaides T, et al,. LT. Transplantation: Impact of pretransplant renal insufficiency. Liver Transplant 2008; 14: 665-671.
7. Nadim MK, Genyk YS, Tokin C, et al,. Impact of the etiology of acute kidney injury on outcomes following liver transplantation: Acute tubular necrosis versus hepatorenal syndrome. Liver Transplant 2012; 18: 539-548.
8. Ruiz R, Kunitake H, Wilkinson AH, et al,. Long-term analysis of combined liver and kidney transplantation at a single center. Archives of Surgery 2006; 141: 735-742.
9. Fraley DS, Brr R, Bernardini J, Angus D, Kramer DJ, Johnson JP,. Impact of acure renal failutre in mortality in end-stage liver disease with or without transplantation. Kidney Int 1998; 54: 518-524.
10. Gonwa TA, Mai ML, Melton LB, et al,. Renal replacement therapy and orthotopic liver transplantation: The role of continuous veno-venous hemodialysis. Transplantation 2001; 71: 1424-1428.
11. Martin EF, Huang J, Xiang Q, Klein JP, Bajaj J, Saeian K,. Recipient and graft survival are not diminished by simultaneous liver-kidney transplantation: An analysis of the UNOS database. Liver Transplant 2012. Mar 29 [Epub ahead of print].
12. Davis CL,. Impact of pretransplant renal failure: When is listing for kidney-liver indicated? Liver Transplant 2005; 11 (Suppl 2): S35-S44.
13. Simpson N, Cho YW, Cicciarelli JC, Selby RR, Fong TL,. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS database. Transplantation 2006; 82: 1298-1303.
14. Davis CL, Gonwa TA, Wilkinson AH,. Identification of patients best suited for combined liver-kidney transplantation: Part II. Liver Transplant 2002; 8: 193-211.
15. Berg UB, Back R, Celsi G, et al,. Comparison of plasma clearance of iohexol and urniary clearance of inulin for measurement of GFR in children. Am J Kidney Dis 2011; 57: 55-61.
16. Gaspari F, Perico N, Ruggenenti P, et al,. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995; 6: 257-263.
17. Brown SC, O'Reilly PH,. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: Evidence for a new gold standard. J Urol 1991; 146: 675-679.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-S266.
19. Francis JM, Palmer MR, Donohoe K, et al,. Evaluation of native kidney recovery after simultaneous liver-kidney transplantation. Transplantation 2012; 93: 530-535.
20. Morton KA, Pisani DE, Whiting JH, Jr., Cheung AK, Arias JM, Valdivia S,. Determination of glomerular filtration rate using technetium-99m-DTPA with differing degrees of renal function. J Nucl Med Technol 1997; 25: 110-114.
21. Rodby RA, Ali A, Rohde RD, Lewis EJ,. Renal scanning 99mTc diethylene-triamine pentaacetic acid glomerular filtration rate (GFR) determination compared with iothalamate clearance GFR in diabetics. The Collaborative Study Group for The study of Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy. Am J Kidney Dis 1992; 20: 569-573.
22. Taber DJ, Fann AL, Malat G, Dupuis RE,. Evaluation of estimated and measured creatinine clearances for predicting the pharmacokinetics of vancomycin in adult liver transplant recipients. Ther Drug Monit 2003; 25: 67-72.
23. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB,. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations. Liver Transplant 2004; 10: 301-309.
24. Cantarovich M, Yoshida EM, Peltekian KM, et al,. Poor prediction of the glomerular filtration rate using current formulas in de novo liver transplant patients. Transplantation 2006; 82: 433-436.
25. Kamar N, Guilbeau-Frugier C, Servais A, et al,. Kidney histology and function in liver transplant patients. Nephrol Dial Transplant 2011; 26: 2355-2361.
26. Ojo AO, Held PJ, Port FK, et al,. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
27. Kastelan S, Ljubicic N, Kastelan Z, Ostojic R, Uravic M,. The role of duplex-doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis. Hepato-Gastroenterology 2004; 51: 1408-1412.
28. Pompili M, Rapaccini GL, De Luca F, et al,. Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation. J Ultrasound Med 1999; 18: 497-502.
29. Querfeld U, Boechat IM, Vargas J, et al,. Renal ultrasound abnormalities in children with end-stage liver disease-reversal by liver transplantation. Pediatr Nephrol 1991; 5: 18-21.
30. Davis CL, Feng S, Sung R, et al,. Simultaneous liver-kidney transplantation: Evaluation to decision making. Am J Transplant 2007; 7: 1702-1709.
31. Haase M, Bellomo R, Devarajan P, Schlattman P, Haase-Fielitz A,. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systemic review and meta-analysis. Am J Kidney Dis 2009; 54: 1012-1024.
32. Yu Y, Jin H, Holder D, et al,. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nature Biotechnol 2010; 28: 470-477.
33. Biancofiore G, Pucci L, Cerutti E, et al,. Cystatin C as a marker of renal function immediately after liver transplantation. Liver Transplant 2006; 12: 285-291.
34. Niemann CU, Walia A, Waldman J, et al,. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transplant 2009; 15: 1852-1860.
35. Boudville N, Salama M, Jeffrey GP, Ferrari P,. The inaccuracy of cystatin C and creatinine-based equations in predicting GFr in orthotopic liver transplant recipients. Nephrol Dial Transplant 2009; 24: 2926-2930.
36. Levitsky J, Salomon DR, Abecassis M, et al,. Clinical and plasma proteomic markers correlating with chronic kidney disease after liver transplantation. Am J Transplant 2011; 11: 1972-1978.
37. Baker TLJ, Jie C, Parikh N, et al,. A novel renal injury proteomic biomarker panel predicts reversibility of renal dysfunction following liver transplanation. Am J Transplant 2011; 11 (Suppl 2): A#536.
38. Biancofiore G, Pucci L, Cerutti E, et al,. Cystatin C as a marker of renal function immediately after liver transplantation. Liver Transplant 2006; 12: 285-291.
39. Niemann CU, Walia A, Waldman J, et al,. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transplant 2009; 15: 1852-1860.
40. Feng S, Goodrich NP, Bragg-Gresham JL, et al,. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
41. Durand F, Renz JF, Alkofer B, et al,. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transplant 2008; 14: 1694-1707.
42. Merion RM, Goodrich NP, Feng S,. How can we define expanded criteria for liver donors? J Hepatol 2006; 45: 484-488.
43. Yamamoto S, Sato Y, Ichida T, Kurosaki I, Nakatsuka H, Hatakeyama K,. Acute renal failure during the early postoperative period in adult living-related donor liver transplantation. Hepato-Gastroenterology 2004; 51: 1815-1819.
44. Lin CC, Chuang FR, Lee CH, et al,. The renal-sparing efficacy of basiliximab in adult living donor liver transplantation. Liver Transplant 2005; 11: 1258-1264.
45. Sellers MT, McGuire BM, Haustein SV, Bynon JS, Hunt SL, Eckhoff DE,. Two-dose daclizumab induction therapy in 209 liver transplants: A single-center analysis. Transplantation 2004; 78: 1212-1217.
46. Soliman T, Hetz H, Burghuber C, et al,. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation. Liver Transplant 2007; 13: 1039-1044.
47. Van Wagner LB, Baker T, Ahya SN, Norvell JP, Wang E, Levitsky J,. Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation. J Hepatol 2009; 51: 874-880.
48. Gittes RF, Rist M, Treves S, Biewiner A,. Autoregulation in rats with transplanted supernumerary kidneys. Nature 1980; 284: 618-620.
49. Silber S, Malvin RL,. Compensatory and obligatory renal growth in rats. Am J Physiol 1974; 226: 114-117.